Literature DB >> 15002729

Effects of the combined treatment of naloxone and indomethacin on catecholamines and behavior after intranigral lipopolysaccharide injection.

Vinchi Wang1, Lie-Gan Chia, Dah-Ren Ni, Lee-Ju Cheng, Yuh-Pin Ho, Fu-Chou Cheng, Jau-Shyong Hong.   

Abstract

The present study examined effects of the combined administration of naloxone (NX) and indomethacin (IM) on nigrostriatal catecholamines and locomotor activity after intranigral lipopolysaccharide (LPS) injection in Sprague-Dawley rats. NX plus IM was given 3 days after LPS injection; it significantly (P < .05) reversed LPS inflammation on nigrostriatal dopamine (DA) and nigral serotonin (5-HT) and nigral homovanillic acid (HVA)/DA ratio and nigrostriatal 5-hydroxyindoleacetic acid (5-HIAA)/5-HT ratio. It also tended to ameliorate the locomotor hyperactivity. However, NX plus IM given 30 min before LPS could not satisfactorily protect against LPS's damage both biochemically and behaviorally. These results reveal that NX plus IM may protect against LPS on DA, 5-HT, and motor function after LPS injection but not before. Thus it suggests that the combined treatment of NX and IM gives a potent therapy, but not prevention, of LPS-induced inflammation and also protect nigrostriatal dopaminergic and serotoninergic systems against LPS in rats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15002729     DOI: 10.1023/b:nere.0000013736.80749.4b

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  32 in total

1.  Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge.

Authors:  M I Masana; M P Heyes; I N Mefford
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1990       Impact factor: 5.067

2.  Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system.

Authors:  A Castaño; A J Herrera; J Cano; A Machado
Journal:  J Neurochem       Date:  1998-04       Impact factor: 5.372

Review 3.  Inflammation in the CNS: balance between immunological privilege and immune responses.

Authors:  M K Matyszak
Journal:  Prog Neurobiol       Date:  1998-10       Impact factor: 11.685

4.  Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

Authors:  S J Kish; K Shannak; O Hornykiewicz
Journal:  N Engl J Med       Date:  1988-04-07       Impact factor: 91.245

5.  Effect of acute lipopolysaccharide administration on (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2 aminopropane-induced wet dog shake behavior in rats: comparison with body weight change and locomotor activity.

Authors:  S Kouhata; A Kagaya; S Nakae; Y Nakata; S Yamawaki
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2001-02       Impact factor: 5.067

6.  Cultured astrocytes react to LPS with increased cyclooxygenase activity and phagocytosis.

Authors:  B Kalmár; A Kittel; R Lemmens; Z Környei; E Madarász
Journal:  Neurochem Int       Date:  2001-04       Impact factor: 3.921

7.  Behavior, neurochemistry and histology after intranigral lipopolysaccharide injection.

Authors:  Peiyuan F Hsieh; Lie-Gan Chia; Dah-Ren Ni; Lee-Ju Cheng; Yuh-Pin Ho; Shun-Fen Tzeng; Ming-Hong Chang; Jau-Shyong Hong
Journal:  Neuroreport       Date:  2002-03-04       Impact factor: 1.837

Review 8.  The effect of naloxone on spontaneous and evoked dopamine release in the central and peripheral nervous systems.

Authors:  J J Feigenbaum; S G Howard
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

Review 9.  MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease.

Authors:  M Gerlach; P Riederer; H Przuntek; M B Youdim
Journal:  Eur J Pharmacol       Date:  1991-12-12       Impact factor: 4.432

10.  Human ramified microglial cells produce nitric oxide upon Escherichia coli lipopolysaccharide and tumor necrosis factor alpha stimulation.

Authors:  M Colasanti; T Persichini; T Di Pucchio; F Gremo; G M Lauro
Journal:  Neurosci Lett       Date:  1995-11-17       Impact factor: 3.046

View more
  3 in total

Review 1.  Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease.

Authors:  Bin Liu
Journal:  AAPS J       Date:  2006-09-29       Impact factor: 4.009

Review 2.  The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery.

Authors:  Garima Dutta; Ping Zhang; Bin Liu
Journal:  Fundam Clin Pharmacol       Date:  2008-08-15       Impact factor: 2.748

3.  Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons.

Authors:  A Machado; A J Herrera; J L Venero; M Santiago; R M de Pablos; R F Villarán; A M Espinosa-Oliva; S Argüelles; M Sarmiento; M J Delgado-Cortés; R Mauriño; J Cano
Journal:  ISRN Neurol       Date:  2011-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.